Tafamidis in transthyretin amyloidosis: a guide to its use in delaying peripheral neurological impairment in patients with stage 1 polyneuropathy Kate McKeageKatherine A. Lyseng-WilliamsonLesley J. Scott Adis Drug Q&A 10 December 2016 Pages: 47 - 53
Erratum to: Tafamidis in transthyretin amyloidosis: a guide to its use in delaying peripheral neurological impairment in patients with stage 1 polyneuropathy Kate McKeageKatherine A. Lyseng-WilliamsonLesley J. Scott Erratum 01 February 2017 Pages: 54 - 55
Uridine triacetate in the emergency treatment of fluorouracil or capecitabine overdose or toxicity: a guide to its use Katherine A. Lyseng-Williamson Adis Drug Q&A 10 December 2016 Pages: 56 - 61
Manage chronic pain during pregnancy with selected analgesics Adis Medical Writers Disease Management 02 November 2016 Pages: 62 - 65
Take care when using lithium with other drugs, as clinically relevant interactions may occur Adis Medical Writers Drug Reactions and Interactions 22 November 2016 Pages: 66 - 69
First reports of adverse drug reactions Drug Reactions and Interactions 07 January 2017 Pages: 70 - 71
News from the 45th ESCP Symposium on Clinical Pharmacy, 4–6 October 2016, Oslo Katherine A. Lyseng-Williamson Practical Issues and Updates 07 January 2017 Pages: 72 - 76
Telmisartan: clinical evidence across the cardiovascular and renal disease continuum Piyush Patel Review Article 07 December 2016 Pages: 77 - 87
Attitudes and knowledge of community pharmacy professionals regarding the spontaneous reporting of adverse drug reactions: a preliminary study in Coimbra, Portugal Cristiano MatosJoão JoaquimTimóteo Pires Original Research Article 26 October 2016 Pages: 88 - 94